Products Affected - Description
Cupric sulfate injection, American Regent
0.4 mg/mL 10 mL vial (NDC 00517-6210-25)
Reason for the Shortage
American Regent has cupric sulfate on shortage due to manufacturing delays.
Cupric chloride injection, Hospira
0.4 mg/mL 10 mL vial (NDC 00409-4092-01)
Estimated Resupply Dates
- American Regent has cupric sulfate 0.4 mg/mL 10 mL vials on back order and the company cannot estimate a release date.
- Hospira has been supplying the market for several months.
October 7, 2014; August 25, 2014; July 25, 2014; July 8, 2014; April 25, 2014; March 25, 2014; February 10, 2014; December 27, 2013; December 4, 2013; October 11, 2013; August 12, 2013; June 6, 2013; May 28, 2013; March 11, 2013; January 2, 2013; December 17, 2012; November 13, 2012; August 22, 2012; June 27, 2012; April 24, 2012; March 22, 2012; January 31, 2012; December 27, 2011; November 9, 2011; October 11, 2011; September 14, 2011; August 25, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins